Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial

被引：0
|
作者：
Ribi, K. E. [1 ]
Phillips, K. A. [1 ]
Sun, Z. [1 ]
Stephens, A. [1 ]
Thompson, A. [1 ]
Harvey, V. [1 ]
Thuerlimann, B. [1 ]
Cardoso, F. [1 ]
Coates, A. S. [1 ]
Bernhard, J. [1 ]
机构：
[1] IBCSG, BIG1 98 Collaborat Grp, Bern, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
510
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Dieter Koeberle
    Beat Thuerlimann
    Breast Cancer Research and Treatment, 2008, 112 (2) : 387 - 387
  • [22] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Dieter Koeberle
    Beat Thuerlimann
    Breast Cancer Research and Treatment, 2007, 105 : 55 - 66
  • [23] DESIGN AND EVOLUTION OF BIG 1-98: A RANDOMIZED, DOUBLE-BLIND, PHASE-III STUDY COMPARING LETROZOLE AND TAMOXIFEN AS ADJUVANT ENDOCRINE THERAPY FOR POSTMENOPAUSAL WOMEN WITH RECEPTOR-POSITIVE, EARLY BREAST CANCER - BIG 1-98 COLLABORATIVE AND INTERNATIONAL BREAST CANCER STUDY GROUPS
    Giobbie-Hurder, A. E.
    Gelber, R. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 80 - 80
  • [24] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Koeberle, Dieter
    Thuerlimann, Beat
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (Suppl 1) : 55 - 66
  • [25] Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
    Viale, Giuseppe
    Giobbie-Hurder, Anita
    Regan, Meredith M.
    Coates, Alan S.
    Mastropasqua, Mauro G.
    Dell'Orto, Patrizia
    Maiorano, Eugenio
    MacGrogan, Gaetan
    Braye, Stephen G.
    Oehlschlegel, Christian
    Neven, Patrick
    Orosz, Zsolt
    Olszewski, Wojciech P.
    Knox, Fiona
    Thuerlimann, Beat
    Price, Karen N.
    Castiglione-Gertsch, Monica
    Gelber, Richard D.
    Gusterson, Barry A.
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5569 - 5575
  • [26] Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
    Metzger Filho, Otto
    Giobbie-Hurder, Anita
    Mallon, Elizabeth
    Gusterson, Barry
    Viale, Giuseppe
    Winer, Eric P.
    Thuerlimann, Beat
    Gelber, Richard D.
    Colleoni, Marco
    Ejlertsen, Bent
    Debled, Marc
    Price, Karen N.
    Regan, Meredith M.
    Coates, Alan S.
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) : 2772 - U85
  • [27] Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer:: The BIG 1-98 trial
    Crivellari, Diana
    Sun, Zhuoxin
    Coates, Alan S.
    Price, Karen N.
    Thuerlimann, Beat
    Mouridsen, Henning
    Mauriac, Louis
    Forbes, John F.
    Paridaens, Robert J.
    Castiglione-Gertsch, Monica
    Gelber, Richard D.
    Colleoni, Marco
    Lang, Istvan
    Del Mastro, Lucia
    Gladieff, Laurence
    Rabaglio, Manuela
    Smith, Ian E.
    Chirgwin, Jacquie H.
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 1972 - 1979
  • [28] The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer
    Monnier, Alain M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (05) : 627 - 634
  • [29] Letrozole is cost-effective versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer: BIG-1-98
    Karnon, J.
    Johnston, S. R. D.
    Delea, T.
    Barghout, V.
    Thomas, S.
    Papo, N. L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 96 - 96
  • [30] Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98
    Alkner, S.
    Jensen, M. -B.
    Rasmussen, B. B.
    Bendahl, P. -O.
    Ferno, M.
    Ryden, L.
    Mouridsen, H.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (02) : 481 - 490
12345